Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
NCT ID: NCT00393471
Last Updated: 2023-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
615 participants
INTERVENTIONAL
2000-10-31
2001-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Etanercept
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion:
\- A history or presence of clinically important medical disease.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Trial Manager
Role: PRINCIPAL_INVESTIGATOR
For Denmark, Finland, Norway, and Sweden, [email protected]
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Leonards, New South Wales, Australia
Adelaide, , Australia
Southport, , Australia
Vienna, , Austria
Brussels, , Belgium
Diepenbeek, , Belgium
Ghent, , Belgium
Leuven, , Belgium
Liège, , Belgium
Česká Lípa, , Czechia
Prague, , Czechia
Terezín, , Czechia
Zlín, , Czechia
Copenhagen, , Denmark
Herlev, , Denmark
Kuopio, , Finland
Rauma, , Finland
Tampere, , Finland
Vantaa, , Finland
Bordeaux, , France
Brest, , France
Créteil, , France
Grenoble, , France
Le Kremlin-Bicêtre, , France
Montpellier, , France
Nice, , France
Paris, , France
Paris, , France
Paris, , France
Rouen, , France
Strasbourg, , France
Toulouse, , France
Berlin, , Germany
Cologne, , Germany
Erlangen, , Germany
Herne, , Germany
Leipzig, , Germany
München, , Germany
Plauen, , Germany
Vogelsang, , Germany
Würzburg, , Germany
Athens, , Greece
Thessaloniki, , Greece
Jerusalem, , Israel
Petah Tikva, , Israel
Ferrara, , Italy
Florence, , Italy
Genova, , Italy
Milan, , Italy
Milan, , Italy
Napoli, , Italy
Pavia, , Italy
Udine, , Italy
Alkmaar, , Netherlands
Arnhem, , Netherlands
Doetinchem, , Netherlands
Enschede, , Netherlands
Leeuwarden, , Netherlands
Maastricht, , Netherlands
Nijmegen, , Netherlands
Tilburg, , Netherlands
Venlo, , Netherlands
Drammen, , Norway
Oslo, , Norway
Elblag, , Poland
Kalisz, , Poland
Krakow, , Poland
Warsaw, , Poland
Wroclaw, , Poland
Lisbon, , Portugal
Lisbon, , Portugal
Bucharest, , Romania
Cluj-Japoca, , Romania
Barcelona, , Spain
Guadalajara, , Spain
Madrid, , Spain
Madrid, , Spain
Madrid, , Spain
Santander, , Spain
Santiago de Compostela, , Spain
Jönköping, , Sweden
Kalmar, , Sweden
Linköping, , Sweden
Stockholm, , Sweden
Uppsala, , Sweden
London, , United Kingdom
North Yorks, , United Kingdom
Trent, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gallo G, Brock F, Kerkmann U, Kola B, Huizinga TW. Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage. RMD Open. 2016 Apr 21;2(1):e000186. doi: 10.1136/rmdopen-2015-000186. eCollection 2016.
van der Heijde D, Klareskog L, Landewe R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2007 Dec;56(12):3928-39. doi: 10.1002/art.23141.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0881A1-308
Identifier Type: -
Identifier Source: org_study_id